Abstract:Nicotinamide adenine dinucleotide (NAD + ), a coenzyme for more than 500 enzymes, plays a central role in energy production, metabolism, cellular signaling, and DNA repair. Until recently, NAD + was primarily considered to be an intracellular molecule (iNAD + ), however, its extracellular species (eNAD + ) has recently been discovered and has since been associated with a multitude of pathological conditions. Therefore, accurate quantification of eNAD + in bodily fluids such as plasma is paramount to answer important research questions. In order to create a clinically meaningful and reliable quantitation method, we analyzed the relationship of cell lysis, routine clinical laboratory parameters, blood collection techniques, and pre-analytical processing steps with measured plasma eNAD + concentrations. Initially, NAD + levels were assessed both intracellularly and extracellularly. Intriguingly, the concentration of eNAD + in plasma was found to be approximately 500 times lower than iNAD + in peripheral blood mononuclear cells (0.253 ± 0.02 μM vs. 131.8 ± 27.4 μM, p = 0.007, respectively). This stark contrast suggests that cellular damage or cell lysis could potentially affect the levels of eNAD + in plasma. However, systemic lactate dehydrogenase in patient plasma, a marker of cell damage, did not significantly correlate with eNAD + ( n = 33; r = −0.397; p = 0.102). Furthermore, eNAD + was negatively correlated with increasing c-reactive protein (CRP, n = 33; r = −0.451; p = 0.020), while eNAD + was positively correlated with increasing hemoglobin ( n = 33; r = 0.482; p = 0.005). Next, variations in blood drawing, sample handling and pre-analytical processes were examined. Sample storage durations at 4°C (0–120 min), temperature (0° to 25°C), cannula sizes for blood collection and tourniquet times (0 – 120 s) had no statistically significant effect on eNAD + ( p > 0.05). On the other hand, prolonged centrifugation (> 5 min) and a faster braking mode of the centrifuge rotor (< 4 min) resulted in a significant decrease in eNAD + levels ( p < 0.05). Taken together, CRP and hemoglobin appeared to be mildly correlated with eNAD + levels whereas cell damage was not correlated significantly to eNAD + levels. The blood drawing trial did not show any influence on eNAD + , in contrast, the preanalytical steps need to be standardized for accurate eNAD + measurement. This work paves the way towards robust eNAD + measurements, for use in future clinical and translational research, and provides an optimized hands-on protocol for reliable eNAD + quantification in plasma.

Adaptation of a Commercial NAD+ Quantification Kit to Assay the Base-Exchange Activity and Substrate Preferences of SARM1

A fluorometric assay of SIRT1 deacetylation activity through quantification of nicotinamide adenine dinucleotide.

SARM1 is a multi-functional NAD(P)ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolites

Base-Exchange Enabling the Visualization of SARM1 Activities in Sciatic Nerve-Injured Mice

Programmed axon death executor SARM1 is a multi-functional NAD(P)ase with prominent base exchange activity, all regulated by physiological levels of NMN, NAD, NADP and other metabolites

Synthesis, Biological, and Computational Evaluations of Conformationally Restricted NAD-Mimics as Discriminant Inhibitors of Human NMN-Adenylyltransferase Isozymes

Development of a Capillary Electrophoresis Method for Analyzing Adenosine Deaminase and Purine Nucleoside Phosphorylase and Its Application in Inhibitor Screening

A One-Step Specific Assay for Continuous Detection of Sirtuin 2 Activity

Nicotinic Acid Mononucleotide is an Allosteric SARM1 Inhibitor Promoting Axonal Protection.

A High‐Throughput Continuous Spectroscopic Assay to Measure the Activity of Natural Product Methyltransferases

Molecular beacon based bioassay for highly sensitive and selective detection of nicotinamide adenine dinucleotide and the activity of alanine aminotransferase.

Permeant fluorescent probes visualize the activation of SARM1 and uncover an anti-neurodegenerative drug candidate

Investigation of adenosine A1 receptor-mediated β-arrestin 2 recruitment using a split-luciferase assay

Characterization of Novel SARM1 Inhibitors for the Treatment of Chemotherapy-Induced Peripheral Neuropathy

A homogeneous, high-throughput-compatible, fluorescence intensity-based assay for UDP-N-acetylenolpyruvylglucosamine reductase (MurB) with nanomolar product detection.

Pyridine-based small molecule inhibitors of SARM1 alleviate cell death caused by NADase activity.

A Novel Cycling Assay for Nicotinic Acid-Adenine Dinucleotide Phosphate with Nanomolar Sensitivity

A conformation-specific nanobody targeting the nicotinamide mononucleotide-activated state of SARM1

Optimized protocol for quantification of extracellular nicotinamide adenine dinucleotide: evaluating clinical parameters and pre-analytical factors for translational research

Small molecule substrates for the rapid quantification of acyl transfer activity of nylon hydrolase NylCA

Cell-permeable nicotinamide adenine dinucleotides for exploration of cellular protein ADP-ribosylation